|
OMIM |
Link |
Information gain |
01 |
|
IGES
|
[NCBI]
|
0.00198479
|
|
|
stature quantitative trait locus 2
|
[NCBI]
|
0.00168055
|
|
|
BMND3
|
[NCBI]
|
0.00124824
|
|
|
HDLCQ1
|
[NCBI]
|
0.00101985
|
|
|
body mass index quantitative trait locus on chromosome 13
|
[NCBI]
|
0.00101985
|
|
|
creatinine clearance quantitative trait locus
|
[NCBI]
|
0.00101985
|
|
|
abdominal obesity-metabolic syndrome quantitative trait locus 2
|
[NCBI]
|
0.00101985
|
|
|
body mass index quantitative trait locus on chromosome 7
|
[NCBI]
|
0.00101985
|
|
|
stature quantitative trait locus 4
|
[NCBI]
|
0.00101985
|
|
|
SLI2
|
[NCBI]
|
0.000755546
|
|
|
DYX9
|
[NCBI]
|
0.000755546
|
|
|
BMND5
|
[NCBI]
|
0.000755546
|
|
|
hypertension, essential, susceptibility to, 2
|
[NCBI]
|
0.000755546
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.000755546
|
|
|
SLI1
|
[NCBI]
|
0.000755546
|
|
|
AUTS10
|
[NCBI]
|
0.000656357
|
|
|
stature quantitative trait locus 5
|
[NCBI]
|
0.000656357
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.000656357
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.000656357
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000649394
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.000592265
|
|
|
obesity quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000592265
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000592265
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.000592265
|
|
|
OB10P
|
[NCBI]
|
0.000592265
|
|
|
DYX6
|
[NCBI]
|
0.000592265
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000592265
|
|
|
stature quantitative trait locus 6
|
[NCBI]
|
0.000592265
|
|
|
eosinophilia, familial
|
[NCBI]
|
0.000592265
|
|
|
gout susceptibility 1
|
[NCBI]
|
0.000592265
|
|
|
HBFQTL4
|
[NCBI]
|
0.000592265
|
|
|
x inactivation, familial skewed, 2
|
[NCBI]
|
0.000544842
|
|
|
leptin, serum levels of
|
[NCBI]
|
0.000544842
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.000507236
|
|
|
DYX2
|
[NCBI]
|
0.000504977
|
|
|
neuroticism
|
[NCBI]
|
0.000449609
|
|
|
SCZD6
|
[NCBI]
|
0.000426549
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.000387918
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
0.000371419
|
|
|
MYP2
|
[NCBI]
|
0.000342561
|
|
|
GPS
|
[NCBI]
|
0.000306908
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.000296565
|
|
|
SCZD3
|
[NCBI]
|
0.000286849
|
|
|
HBFQTL2
|
[NCBI]
|
0.000231871
|
|
|
polycystic kidneys
|
[NCBI]
|
0.00019953
|
|
|
PCOS1
|
[NCBI]
|
0.000173366
|
|
|
alcohol dependence
|
[NCBI]
|
0.000145887
|
|
|
polycystic bone disease
|
[NCBI]
|
0.000141555
|
|
|
IGER
|
[NCBI]
|
0.000123988
|
|
|
CMM
|
[NCBI]
|
0.000121314
|
|
|
aortic valve disease
|
[NCBI]
|
0.000120235
|
|
|
ARPKD
|
[NCBI]
|
0.000114436
|
|
|
NIDDM
|
[NCBI]
|
0.000108074
|
|
|
hypertension, essential
|
[NCBI]
|
0.000103769
|
|
|
autism
|
[NCBI]
|
9.65886e-05
|
|
|
carotid intimal medial thickness 1
|
[NCBI]
|
9.65415e-05
|
|
|
EEG
|
[NCBI]
|
9.65415e-05
|
|
|
cd4/cd8 t-cell ratio
|
[NCBI]
|
9.14963e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
9.14963e-05
|
|
|
ADHD
|
[NCBI]
|
8.90488e-05
|
|
|
body mass index
|
[NCBI]
|
8.41415e-05
|
|
|
RBP4
|
[NCBI]
|
8.09446e-05
|
|
|
MAOB
|
[NCBI]
|
7.98147e-05
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
7.87926e-05
|
|
|
BDA1
|
[NCBI]
|
7.45891e-05
|
|
|
OCD1
|
[NCBI]
|
7.45891e-05
|
|
|
BMND1
|
[NCBI]
|
7.11277e-05
|
|
|
IGF2
|
[NCBI]
|
6.93787e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
6.56311e-05
|
|
|
SPCH1
|
[NCBI]
|
6.56311e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
6.44689e-05
|
|
|
factor xii deficiency
|
[NCBI]
|
6.44689e-05
|
|
|
TUB
|
[NCBI]
|
6.35921e-05
|
|
|
MAFD1
|
[NCBI]
|
6.12073e-05
|
|
|
osteoporosis
|
[NCBI]
|
5.86634e-05
|
|
|
CMM2
|
[NCBI]
|
5.86634e-05
|
|
|
FPLD2
|
[NCBI]
|
5.35581e-05
|
|
|
FCHL
|
[NCBI]
|
5.29287e-05
|
|
|
HSR
|
[NCBI]
|
5.19349e-05
|
|
|
POAG
|
[NCBI]
|
4.85302e-05
|
|
|
LPA
|
[NCBI]
|
4.47663e-05
|
|
|
TCF7L2
|
[NCBI]
|
4.374e-05
|
|
|
ABCA1
|
[NCBI]
|
4.374e-05
|
|
|
VWS
|
[NCBI]
|
4.26897e-05
|
|
|
respiratory rhythmicity in sleep
|
[NCBI]
|
3.83957e-05
|
|
|
ALS1
|
[NCBI]
|
3.82705e-05
|
|
|
IBD1
|
[NCBI]
|
3.77195e-05
|
|
|
MTTR
|
[NCBI]
|
3.5285e-05
|
|
|
PTPRJ
|
[NCBI]
|
3.32658e-05
|
|
|
CTNNA3
|
[NCBI]
|
3.32658e-05
|
|
|
GABRB1
|
[NCBI]
|
3.32658e-05
|
|
|
ACE
|
[NCBI]
|
3.30021e-05
|
|
|
CDKN2A
|
[NCBI]
|
3.21629e-05
|
|
|
CDKAL1
|
[NCBI]
|
3.17648e-05
|
|
|
NPR1
|
[NCBI]
|
3.17648e-05
|
|
|
NPHP3
|
[NCBI]
|
3.05692e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
3.03187e-05
|
|
|
LEP
|
[NCBI]
|
2.96719e-05
|
|
|
IGF2BP2
|
[NCBI]
|
2.95754e-05
|
|
|
PNOC
|
[NCBI]
|
2.95754e-05
|
|
|
SLC30A8
|
[NCBI]
|
2.95754e-05
|
|
|
CTF1
|
[NCBI]
|
2.87249e-05
|
|
|
GCKR
|
[NCBI]
|
2.79816e-05
|
|
|
CD19
|
[NCBI]
|
2.73215e-05
|
|
|
ACE2
|
[NCBI]
|
2.73215e-05
|
|
|
NPPB
|
[NCBI]
|
2.67279e-05
|
|
|
CDKN2B
|
[NCBI]
|
2.61886e-05
|
|
|
MYF5
|
[NCBI]
|
2.61886e-05
|
|
|
DGAT1
|
[NCBI]
|
2.61886e-05
|
|
|
HHEX
|
[NCBI]
|
2.56946e-05
|
|
|
RGS2
|
[NCBI]
|
2.52388e-05
|
|
|
ATP1A1
|
[NCBI]
|
2.52388e-05
|
|
|
PXE
|
[NCBI]
|
2.48246e-05
|
|
|
MAP1A
|
[NCBI]
|
2.48158e-05
|
|
|
MC3R
|
[NCBI]
|
2.40515e-05
|
|
|
NCF1
|
[NCBI]
|
2.40515e-05
|
|
|
ALOX5
|
[NCBI]
|
2.40515e-05
|
|
|
IL9
|
[NCBI]
|
2.30643e-05
|
|
|
PCDH15
|
[NCBI]
|
2.30643e-05
|
|
|
APOB
|
[NCBI]
|
2.24715e-05
|
|
|
DBH
|
[NCBI]
|
2.22198e-05
|
|
|
CAPN10
|
[NCBI]
|
2.19634e-05
|
|
|
CDH23
|
[NCBI]
|
2.17178e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
2.14821e-05
|
|
|
INS
|
[NCBI]
|
2.12832e-05
|
|
|
CD4
|
[NCBI]
|
2.10374e-05
|
|
|
CHGA
|
[NCBI]
|
2.04284e-05
|
|
|
AD
|
[NCBI]
|
2.02722e-05
|
|
|
KCNJ11
|
[NCBI]
|
2.02388e-05
|
|
|
RARA
|
[NCBI]
|
1.95368e-05
|
|
|
IL13
|
[NCBI]
|
1.93739e-05
|
|
|
BCL6
|
[NCBI]
|
1.92154e-05
|
|
|
LIF
|
[NCBI]
|
1.86217e-05
|
|
|
USF1
|
[NCBI]
|
1.80835e-05
|
|
|
HBG2
|
[NCBI]
|
1.75915e-05
|
|
|
KIT
|
[NCBI]
|
1.68209e-05
|
|
|
GNRHR
|
[NCBI]
|
1.66186e-05
|
|
|
NAT1
|
[NCBI]
|
1.66186e-05
|
|
|
VDR
|
[NCBI]
|
1.61852e-05
|
|
|
ITGB3
|
[NCBI]
|
1.61423e-05
|
|
|
CD36
|
[NCBI]
|
1.57882e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
1.56262e-05
|
|
|
APOD
|
[NCBI]
|
1.55365e-05
|
|
|
IL10
|
[NCBI]
|
1.53747e-05
|
|
|
H6PD
|
[NCBI]
|
1.52956e-05
|
|
|
MC4R
|
[NCBI]
|
1.52956e-05
|
|
|
UGB
|
[NCBI]
|
1.48427e-05
|
|
|
CPE
|
[NCBI]
|
1.3612e-05
|
|
|
GH1
|
[NCBI]
|
1.33845e-05
|
|
|
PRLR
|
[NCBI]
|
1.33845e-05
|
|
|
IL4
|
[NCBI]
|
1.33845e-05
|
|
|
LMNA
|
[NCBI]
|
1.33291e-05
|
|
|
CPB2
|
[NCBI]
|
1.30601e-05
|
|
|
PPARG
|
[NCBI]
|
1.25112e-05
|
|
|
UCN
|
[NCBI]
|
1.24171e-05
|
|
|
GTS
|
[NCBI]
|
1.17857e-05
|
|
|
DDC
|
[NCBI]
|
1.16777e-05
|
|
|
IL6
|
[NCBI]
|
1.08868e-05
|
|
|
SLC2A4
|
[NCBI]
|
1.08519e-05
|
|
|
CDK4
|
[NCBI]
|
1.00193e-05
|
|
|
IHH
|
[NCBI]
|
9.93139e-06
|
|
|
PRNP
|
[NCBI]
|
9.25246e-06
|
|
|
VEGF
|
[NCBI]
|
8.28092e-06
|
|
|
SERPINA6
|
[NCBI]
|
8.18341e-06
|
|
|
NF1
|
[NCBI]
|
8.0031e-06
|
|
|
SOD1
|
[NCBI]
|
7.86743e-06
|
|
|
NPY
|
[NCBI]
|
6.94639e-06
|
|
|
LCAT
|
[NCBI]
|
6.82765e-06
|
|
|
LDLR
|
[NCBI]
|
6.81244e-06
|
|
|
GHRH
|
[NCBI]
|
6.03485e-06
|
|
|
NPPA
|
[NCBI]
|
4.88067e-06
|
|
|
CNTF
|
[NCBI]
|
3.04211e-06
|
|
|
TNF
|
[NCBI]
|
2.78779e-06
|
|
|
AHR
|
[NCBI]
|
2.28199e-06
|
|
|
TG
|
[NCBI]
|
1.72161e-06
|
|
|
RA
|
[NCBI]
|
1.60533e-06
|
|
|
EGFR
|
[NCBI]
|
9.83054e-07
|
|
|
TH
|
[NCBI]
|
3.32379e-07
|
|